Casati Costanza, Colombo Valeriana Giuseppina, Perrino Marialuisa, Rossetti Ornella Marina, Querques Marialuisa, Giacomoni Alessandro, Binaggia Agnese, Colussi Giacomo
Division of Nephrology, Dialysis and Kidney Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Division of Transplant Surgery, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
J Transplant. 2018 May 16;2018:4141756. doi: 10.1155/2018/4141756. eCollection 2018.
Grafts from elderly donors (ECD) are increasingly allocated to single (SKT) or dual (DKT) kidney transplantation according to biopsy score. Indications and benefits of either procedure lack universal agreement.
A total of 302 ECD-transplants in period from Jan 1, 2000, to Dec 31, 2015, were allocated to SKT (SKT) on clinical grounds alone (before Dec 2010, pre-DKT era, = 170) or according to a clinical-histological protocol (after Dec 2010, DKT era, = 132) to DKT ( = 48), SKT biopsy-based protocol ("high-risk", SKT, = 51), or SKT clinically based protocol ("low-risk", SKT, = 33). Graft and patient survival were compared between the two periods and between different transplant categories.
Graft and overall survival in recipients from ECD in pre-DKT and DKT era did not differ (5-year graft survival 87.7% and 84.2%, resp.); equal survival in the 2 ECD periods was shown in both donor age ranges of 60-69 and >70-years, and in low-risk or high-risk ECD categories. Within the DKT protocol SKT showed worst graft and overall survival in the 60-69 donor age range; DKT did not result in significantly better outcome than SKT from ECD in either era. One-year posttransplant creatinine clearance in recipients did not differ between any ECD transplant category. At 3 and 5 years after transplantation there were significantly higher total dialysis-free recipient life years from an equal donor number in the pre-DKT era than in the DKT protocol.
Use of a biopsy-based protocol to allocate grafts from aged donors to SKT or DKT did not result in better short term graft survival than a clinically based protocol with allocation only to SKT and reduced overall recipient dialysis-free life years in time.
根据活检评分,老年供体(ECD)的移植物越来越多地被分配用于单肾移植(SKT)或双肾移植(DKT)。这两种手术的适应症和益处尚未达成普遍共识。
2000年1月1日至2015年12月31日期间,共有302例ECD移植,其中仅根据临床理由(2010年12月之前,DKT前时代,n = 170)分配至SKT(SKT组),或根据临床组织学方案(2010年12月之后,DKT时代,n = 132)分配至DKT(n = 48)、基于活检方案的SKT(“高风险”,SKT组,n = 51)或基于临床方案的SKT(“低风险”,SKT组,n = 33)。比较两个时期以及不同移植类别之间的移植物和患者生存率。
DKT前和DKT时代ECD受者的移植物和总体生存率无差异(5年移植物生存率分别为87.7%和84.2%);在60 - 69岁和>70岁这两个供体年龄范围以及低风险或高风险ECD类别中,两个ECD时期的生存率均相等。在DKT方案中,SKT在60 - 69岁供体年龄范围内的移植物和总体生存率最差;在任何一个时代,DKT的结果均未显著优于ECD的SKT。各ECD移植类别受者移植后1年的肌酐清除率无差异。移植后3年和5年,与DKT方案相比,DKT前时代相同供体数量的受者无透析总生存年数显著更高。
使用基于活检的方案将老年供体的移植物分配至SKT或DKT,与仅分配至SKT的基于临床的方案相比,短期移植物生存率并未提高,且随着时间推移受者无透析总生存年数减少。